ALM

(redirected from Acral lentiginous melanoma)
Also found in: Dictionary, Medical, Wikipedia.

alm

[älm]
(ecology)
A meadow in alpine or subalpine mountain regions.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.

ALM

On drawings, abbr. for “alarm.”
McGraw-Hill Dictionary of Architecture and Construction. Copyright © 2003 by McGraw-Hill Companies, Inc.

ALM

This article is provided by FOLDOC - Free Online Dictionary of Computing (foldoc.org)

application lifecycle management

The administration and control of an application from inception to its demise. Application lifecycle management (ALM) embraces requirements management, system design, software development and configuration management. It implies an integrated set of tools for developing and controlling the project. See requirements management, system development life cycle and configuration management.

AppWare

An earlier client/server development system from Novell that supported Windows and Mac clients. It included Novell's Visual AppBuilder programming tool, which was used to create applications by linking pre-built Application Loadable Modules (ALMs) together. ALMs communicated with each other over a "software bus" known as the AppWare Bus.

Foundation libraries for Windows, Mac, OS/2, NT, Solaris, HP and UnixWare were originally created to provide cross-platform portability. However, in late 1994, Novell dropped the libraries, while continuing with Visual AppBuilder for Windows and Macintosh. Some of AppWare's Visual AppBuilder features and functionality were carried forward in Novell's exteNd product suite.
Copyright © 1981-2019 by The Computer Language Company Inc. All Rights reserved. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction is strictly prohibited without permission from the publisher.
References in periodicals archive ?
2014 Piana et al, (70) 2015 Donigan et al, (71) 2017 Abbreviations: ALM, acral lentiginous melanoma; AN, atypical/ dysplastic nevi; BN, benign nevi/melanocytic lesion; C, cytoplasmic; CBN, cellular blue nevus; LM, lentigo maligna; LMM, lentigo maligna melanoma; MIS, melanoma in situ; MM, metastatic melanoma; N, nuclear; NA, not available; NM, nodular melanoma; NSLN, nonsentinel lymph node; PAM, primary acquired melanosis (conjunctival); PIM, primary invasive melanoma; RGP, radial growth phase; SLN, sentinel lymph node; SSM, superficial spreading melanoma; VGP, vertical growth phase.
Dermoscopic features of an intracorneal or subcorneal hematoma may mimic initial acral lentiginous melanoma or melanoma in situ [1,4,5].
(4) Melanoma is classified into five major histological subtypes: nodular melanoma (NM), lentigo maligna melanoma (LMM), superficial spreading melanoma (SSM), acral lentiginous melanoma (ALM), and desmoplastic melanoma (DM).
Acral lentiginous melanoma is the most common histogenetic type and accounts for 75% of all melanomas found in the black population.
The most common specific histologic diagnosis reported was melanoma in situ (22.3%) followed by lentigo maligna (9.3%), nodular melanoma (5.6%), superficial spreading melanoma (5.3%), lentigo maligna melanoma (4.7%), and acral lentiginous melanoma (4.6%).
Acral lentiginous melanoma appears most frequently on the palms of the hands or the soles of the feet, on the undersurface of the fingers or toes, and under the nails.
The black population is also more likely to have advanced disease once detected since the most common type of melanoma in blacks is the aggressive acral lentiginous melanoma. The Skin Cancer Foundation suggests African-Americans examine their skin every three months, seek an annual professional skin examination and make sure doctors remain alert to the possibility of melanoma.
The term AM includes all histopathological subtypes of melanoma that occur at acral sites, including acral lentiginous melanoma (ALM), which comprises up to 80% of all AMs.
Four major clinical subtypes of primary cutaneous melanoma have been described (1) They are superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma and lentigo maligna melanoma.